معرفی
Dr. Paul W. R. Harris is an Associate Professor in the School of Chemical Sciences at the University of Auckland's Faculty of Science. With over two decades of research experience, he has established himself as a leading expert in peptide chemistry and natural product synthesis, with particular expertise in antimicrobial peptides and complex cyclic structures. His research bridges organic chemistry and biological applications, focusing on developing novel therapeutic agents to address antimicrobial resistance.
Dr. Harris's research interests span peptide synthesis methodology, natural product total synthesis, antibiotic development, and chemical biology. His work on antimicrobial peptides has been particularly impactful, with contributions spanning Gram-positive pathogens, mycobacterial infections, and challenging Gram-negative bacteria. He has developed innovative synthetic approaches for complex peptide structures including peptaibols, glycopeptides, and lanthipeptides, often incorporating unusual amino acids and structural motifs that confer unique biological properties.
His publication portfolio demonstrates significant contributions to understanding structure-activity relationships in bioactive peptides, with particular emphasis on optimizing therapeutic properties while minimizing toxicity. Recent work has focused on fluorescently labeled peptides for receptor studies, novel conjugation strategies for drug delivery, and S-lipidation approaches to improve antibiotic properties.
Dr. Harris has received recognition through numerous high-impact publications in journals including Journal of the American Chemical Society, ACS Chemical Biology, and Organic Letters. His collaborative research extends across chemistry, pharmacology, and microbiology disciplines, working with experts in receptor pharmacology, antibiotic resistance, and cancer biology.
In addition to his research, Dr. Harris has contributed to peptide synthesis methodology development, including novel approaches to N-methylated amino acids, on-resin cyclizations, and stereoselective syntheses of complex building blocks. His work has provided critical tools for advancing peptide-based therapeutics and understanding their mechanisms of action.
